Anti-Dermatomycosis Skin Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Dermatomycosis is a type of skin disease majorly caused by the infection of different species of dermatophytes, yeast such as Candida species and Malassezia furfur or variety of fungi species like microsporum, genera trichophyton and epidermophyton. These organisms invade into the layer of skin and affect dermal appendices of hair, nails and epidermis. The condition is mainly characterized by colonization of the keratinized layers by these organisms on the surface of patient’s skin. These organisms have rigid cell wall and are complex in structure thus, anti-bacterial agents are not effective against organisms. Anti-dermatomycosis skin drugs like ketoconazole, clotrimazole and others are effectively used for the treatment of infection. These drugs are commonly used to treat conditions like ringworm, athlete’s foot and other systemic fungal infections like cryptococcal meningitis, and other types of infections. In addition, physical examination and microscopic examination of dermal lesions can be helpful to detect the disease condition.
The market of anti-dermatomycosis skin drugs is witnessing positive growth owing to the rise in fungal infections cases globally. World Health Organization (WHO) stated that nearly 20% of the world population is suffering from skin infections and the percentage is even higher in subtropical or tropical areas. In addition, good penetration and distribution of these drugs into hair folicles and horny layers will offer effective treatment in skin infection disorders and hence drives the market growth of anti-dermatomycosis skin drugs. However, less specific actions of anti-fungal drugs restrains the growth of global anti-dermatomycosis skin drugs market. In addition, high rate of side-effects like nausea, vomiting, constipation, hepatitis will restrain the market of anti-dermatomycosis skin drugs. In severe condition, adverse effects like renal toxicity, hypokalaemia, hepatic failure, anaphylactic shock can be developed. Thus, high rate of adverse effects, using these drugs will restrain the market growth of anti-dermatomycosis skin drugs. Additionally, high cost coupled with high rate of unwanted drug interactions of drugs will further restraint the market growth.
The global Anti-Dermatomycosis Skin Drugs market can be segmented on the basis of:
- By Drug Category
- Other Anti Dermatomycosis Skin Drugs
Geographically, North America dominates the global anti-dermatomycosis skin drugs market. The growth of this market in North America is mainly attributed to increase incidence of skin infections. Europe is considered as the second largest region for global anti-dermatomycosis skin drugs market owing to increasing use of anti-dermatomycosis drugs. The market of anti-dermatomycosis skin drugs in Asia-Pacific region holds strong growth opportunities due to favorable climate condition for the development of skin infectious organisms. This factor would ultimately increase the number of patients seeking for the treatment of skin infections hence drives the market growth of anti-dermatomycosis skin drugs market. Additionally, countries like China and India are considered as the major market for anti-dermatomycosis skin drugs market owing to the high demand of these drugs among patient population which will eventually help Asia-Pacific region to grow steadily.
The market of anti-dermatomycosis skin drugs is majorly dominated by the key players like Amplyx Pharmaceuticals, Inc., Vectura Group plc, Pfizer, Inc., AstraZeneca PLC, Eli Lilly and Company, Aparna Biosciences Corporation, Helix BioMedix, Inc., Aegera Therapeutics, Inc., Globeimmune, Inc. and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017